Cargando…

Phase II trial of hypofractionated VMAT-based treatment for early stage breast cancer: 2-year toxicity and clinical results

BACKGROUND: To report toxicity and early clinical outcomes of hypofractionated simultaneous integrated boost (SIB) approach with Volumetric Modulated Arc Therapy (VMAT) as adjuvant treatment after breast-conserving surgery. METHODS: Patients presenting early-stage breast cancer were enrolled in a ph...

Descripción completa

Detalles Bibliográficos
Autores principales: De Rose, Fiorenza, Fogliata, Antonella, Franceschini, Davide, Navarria, Piera, Villa, Elisa, Iftode, Cristina, D’Agostino, Giuseppe, Cozzi, Luca, Lobefalo, Francesca, Mancosu, Pietro, Tomatis, Stefano, Scorsetti, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027088/
https://www.ncbi.nlm.nih.gov/pubmed/27639373
http://dx.doi.org/10.1186/s13014-016-0701-z

Ejemplares similares